NDC properties for "mercaptopurine 50 MG Oral Tablet" (RxCUI 197931)
About this data
The tables show NDC propoerties for mercaptopurine 50 MG Oral Tablet with the RxCUI 197931
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for mercaptopurine 50 MG Oral Tablet (RxCUI 197931)
| ANDA | ANDA040461 |
|---|---|
| ANDA | ANDA040528 |
| ANDA | ANDA040594 |
| MMSL_CODE | BD1968 |
| MMSL_CODE | CD1968 |
| RxCUI | 197931 |
| SNOMEDCT | 326873001 |
| SPL_SET_ID | 15904472-4c32-4224-95d3-eb131a7ff9c8 |
| SPL_SET_ID | 1db50d07-0326-4fb9-aa51-0a2493914e85 |
| SPL_SET_ID | 40b09616-5bb1-4ef8-98cd-d87537254296 |
| SPL_SET_ID | c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658 |
| VUID | 4006511 |
| Prescribable Synonym | mercaptopurine 50 MG Oral Tablet |
| RXNAV_STR | mercaptopurine 50 MG Oral Tablet |
| RxNorm Name | mercaptopurine 50 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 197931) |
NDC Properties
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0054-4581 |
NDC Item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
| Related queries | Properties for NDC 9 0378-3547 |
NDC Item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| Packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |
NDC Item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| Packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 69076-913 |